Related Experiment Videos
In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides
Abstract:
In vitro activity of netilmicin, cefotaxime, amikacin, dibekacin, gentamicin and tobramicin was compared against clinical isolates in Antibiotic Medium 3 at pH 7.1 and human plasma water at pH 7.8. Except against Pseudomonas aeruginosa the aminoglycosides were generally more active in plasma water than in broth. Against P. aeruginosa higher concentrations were required to inhibit or kill the strain in the plasma water. Cefotaxime was not tested against these organisms. Against E. coli, K. pneumoniae and Proteus species cefotaxime was found to be more active than the aminoglucosides, both in broth and plasma water. Its activity against Staph. aureus was markedly less than that of the aminoglycosides. Tobramicin showed a higher activity in plasma water only against Proteus species.
Insights
This study compared the in vitro activity of several antibiotics against clinical bacterial isolates. Aminoglycosides showed better activity in human plasma water, except against Pseudomonas aeruginosa, while cefotaxime was more effective against E. coli and Proteus species.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotic resistance is a growing global health concern.
- Understanding antibiotic efficacy in different physiological environments is crucial for effective treatment.
Purpose of the Study:
- To compare the in vitro antimicrobial activity of selected aminoglycosides and cefotaxime.
- To evaluate antibiotic performance in both a standard laboratory medium and human plasma water.
Main Methods:
- In vitro susceptibility testing of netilmicin, cefotaxime, amikacin, dibekacin, gentamicin, and tobramicin.
- Testing was conducted in Antibiotic Medium 3 (pH 7.1) and human plasma water (pH 7.8).
- Evaluated activity against clinical isolates including E. coli, K. pneumoniae, Proteus species, Staph. aureus, and P. aeruginosa.
Main Results:
- Aminoglycosides generally exhibited greater activity in plasma water compared to broth, with exceptions for Pseudomonas aeruginosa.
- Higher aminoglycoside concentrations were needed to inhibit or kill P. aeruginosa in plasma water.
- Cefotaxime demonstrated superior activity against E. coli, K. pneumoniae, and Proteus species in both media, but was less active against Staph. aureus than aminoglycosides.
- Tobramicin showed enhanced activity in plasma water specifically against Proteus species.
Conclusions:
- Physiological conditions, such as those found in human plasma, significantly influence the in vitro activity of certain antibiotics.
- Aminoglycosides may offer advantages in plasma environments for some bacterial infections, but careful consideration is needed for P. aeruginosa.
- Cefotaxime remains a potent option for specific Gram-negative infections, while aminoglycosides are effective against Staph. aureus.